Journal
American Journal of Clinical Oncology
Publication Date
7-1-2023
Volume
46
Issue
7
First Page
314
Last Page
322
Document Type
Open Access Publication
DOI
10.1097/COC.0000000000001010
Rights and Permissions
Chan JK, Liu J, Song J, Xiang C, Wu E, Kalilani L, Hurteau JA, Thaker PH. Real-world outcomes associated with poly(ADP-ribose) polymerase inhibitor monotherapy maintenance in patients with primary advanced ovarian cancer. Am J Clin Oncol. 2023 Jul 1;46(7):314-322. doi: 10.1097/COC.0000000000001010. © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
Recommended Citation
Chan, John K; Liu, Jinan; Song, Jinlin; Xiang, Cheryl; Wu, Eric; Kalilani, Linda; Hurteau, Jean A.; and Thaker, Premal H., "Real-world outcomes associated with poly(ADP-ribose) polymerase inhibitor monotherapy maintenance in patients with primary advanced ovarian cancer." American Journal of Clinical Oncology. 46, 7. 314 - 322. (2023).
https://digitalcommons.wustl.edu/oa_4/1957
Department
ICTS (Institute of Clinical and Translational Sciences)
